Who owns Genes?

Key details on Genes (Ticker: GCO)

Who owns Genes?

Is GCO a good stock to own? Find out who bought Genes, who sold Genes (GCO) stock, and who holds a large position in Genes.

Fund Name Number of Shares Share Valuation As Of
FMR 3.21M $182.35M Dec. 31, 2015
Damian Sousa 2.84M $161.39M Dec. 31, 2015
Vanguard 1.65M $93.95M Dec. 31, 2015
BlackRock Fund Advisors 1.43M $81.31M Dec. 31, 2015
DIMENSIONAL FUND ADVISORS 1.30M $74.09M Dec. 31, 2015
Royce & Associates 1.26M $71.39M Dec. 31, 2015
Charles Schwab Bank 818666 $13.62M March 31, 2013
Buckingham Capital Management 732320 $44.05M June 30, 2012
Franklin Resources 645358 $36.68M Dec. 31, 2015
LORD, ABBETT & CO 643787 $49.33M Dec. 31, 2014
CHILTON INVESTMENT 632377 $41.47M Sept. 30, 2013
STATE STREET CORPORATION 618158 $35.27M Sept. 30, 2015
Vinik Asset Management 603889 $36.32M June 30, 2012
LOMBARDIA CAPITAL PARTNERS 600277 $39.64M June 30, 2015
Cambiar Investors 598827 $34.18M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 598092 $33.99M Dec. 31, 2015
Pembroke Management 578500 $42.27M Dec. 31, 2013

Who sold Genes?

Fund Name Date Sold Number of Shares Sold Share Valuation
FRIESS ASSOCIATES Sept. 30, 2011 1.05M $54.25M
Inves Sept. 30, 2011 725674 $37.39M
First Trust Advisors June 30, 2011 597623 $31.14M
Wells Fargo & Company March 31, 2011 1.11M $44.33M
Norges Bank Investment Management March 31, 2011 676347 $27.19M